Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410201 · ClinicalTrials.gov registry record · NA
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
A NA study, sponsored by Barnes Retina Institute.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01410201 is a NA study that was terminated before completion, run by Barnes Retina Institute. The registered enrollment target is 6 participants.
The verdict
NCT01410201, a NA study, was terminated before completion, sponsored by Barnes Retina Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant (Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic epiretinal membrane (ERM).
Interventions
- DRUG Dexamethasone Intravitreal Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01410201
The ClinicalTrials.gov registry entry for NCT01410201 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barnes Retina Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone Intravitreal Implant is the first listed.
NCT01410201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01410201 about?
NCT01410201 is a clinical study titled "Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane". The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant (Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic epiretinal membrane (ERM).
What is the current status of trial NCT01410201?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2011-08. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01410201?
The interventions under investigation include: Dexamethasone Intravitreal Implant (DRUG).
Who is sponsoring clinical trial NCT01410201?
This trial is sponsored by Barnes Retina Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.